Anus Laboratories Ltd vs APOLLO HOSPITALS ENTER. L

A side-by-side comparison of Anus Laboratories Ltd (532981) and APOLLO HOSPITALS ENTER. L (APOLLOHOSP) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, APOLLO HOSPITALS ENTER. L leads 532981 vs APOLLOHOSP on 9 of 14 metrics (1 undecided). See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

  • Valuation22
  • Profitability03
  • Growth11
  • Size & financial health13
ValueReturnsMarginGrowthScaleLow debt

Each axis shows this group's split of that metric, scaled so the leader sits at the edge. Relative to each other, not an absolute score.

Valuation

Even

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

0.00
P/E ratio
64.15
0.00
P/B ratio
12.55
0.00%
Dividend yield
0.23%
₹0.14
EPS
₹135.04

Profitability

APOLLOHOSP takes 3/4

How efficiently each company turns capital and sales into profit. Higher is better.

2.28%
Return on equity
22.10%
12.00%
Return on capital
18.00%
15.00%
EBITDA margin even
15.00%
1.17%
Net margin
7.94%

Growth

Even

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

18.21%
Revenue CAGR (3Y)
14.94%
-42.76%
Profit CAGR (3Y)
33.39%

Size & financial health

APOLLOHOSP takes 3/4

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹0 Cr
Market cap
₹1.25L Cr
₹256 Cr
Revenue
₹25,228 Cr
₹3 Cr
Net profit
₹2,003 Cr
0.00
Debt / equity
0.32
Anus Laboratories Ltd
  • + ["Stock is trading at 0.04 times its book value"]
  • ["Though the company is reporting repeated profits, it is not paying out dividend", "Company has low interest coverage ratio.", "Company has a low return on equity of 8.50% over last 3 years.", "Dividend payout has been low at 3.80% of profits over last 3 years", "Company's cost of borrowing seems high"]
APOLLO HOSPITALS ENTER. L
  • + ["Company has delivered good profit growth of 76.2% CAGR over last 5 years", "Company has been maintaining a healthy dividend payout of 17.7%"]
  • ["Stock is trading at 13.4 times its book value", "Company might be capitalizing the interest cost"]
Anus Laboratories Ltd full analysis APOLLO HOSPITALS ENTER. L full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.

532981 vs APOLLOHOSP: Share Price, Valuation & Which to Buy | DocStoX